Bicara Therapeutics Inc. Common Stock
BCAX is Up +11.01% today
You might want to check out Why is BCAX Up Today?
Why Is Bicara Therapeutics Inc. Common Stock (BCAX) Stock Down Today?
Live update on BCAX's stock movement with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.
Summary
Bicara Therapeutics Inc. Common Stock (BCAX) is trading up +11.01% at $10.99, reflecting a positive shift in investor sentiment today. The stock opened at $9.98 and has moved between $9.74 and $11.20 so far.
Trading volume is 2958247, which is 287% above its average, and the price action suggests buying interest.
Technically, BCAX is trading below its 50-day moving average of $12.72 and below its 200-day moving average of $16.64, indicating short-term and long-term weakness.
Analyst sentiment is bullish, with an average 1-year price target of $30.33. Meyka's AI assigns BCAX a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -21.84% in 1 month ($8.59), -26.10% in 1 year ($8.12), and -33.13% in 5 years ($7.35).
In context, the broader Healthcare sector is down -1.14% today, which may be contributing to the move.
View the full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement.
Stay informed and make better investment decisions.
BCAX Technical Signals
Trading below 50-day moving average ($12.72)
Trading below 200-day moving average ($16.64)
Analyst Recommendations
Price Targets
Sector Context
The Healthcare sector is down -1.14% today, with the Biotechnology industry contributing to the decline. This broader context may be weighing on the stock's performance.
Price Forecast
1 Month
$8.59
1 Year
$8.12
3 Years
$7.40
5 Years
$7.35
Is this change significant?
5-Day:-10.73%
1-Month:-33.92%
3-Month:-29.42%
What's next?
Next earnings date: 7/30/2025